Veterinary Antimicrobial Susceptibility Testing Market Research Report by Product (Accessories & Consumables, Automated Ast Instruments, and Culture Media), by Animal Type (Companion Animals and Food-Producing Animals), by End-user, by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19
The Global Veterinary Antimicrobial Susceptibility Testing Market size was estimated at USD 82.60 Million in 2020 and expected to reach USD 89.19 Million in 2021, at a Compound Annual Growth Rate (CAGR) 8.31% from 2020 to 2026 to reach USD 133.37 Million by 2026.
Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.
Market Segmentation & Coverage: This research report categorizes the Veterinary Antimicrobial Susceptibility Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the Veterinary Antimicrobial Susceptibility Testing Market was studied across Accessories & Consumables, Automated Ast Instruments, Culture Media, and Disks & Plates.
Based on Animal Type, the Veterinary Antimicrobial Susceptibility Testing Market was studied across Companion Animals and Food-Producing Animals.
Based on End-user, the Veterinary Antimicrobial Susceptibility Testing Market was studied across Veterinary Reference Laboratories and Veterinary Research Institutes and Universities.
Based on Geography, the Veterinary Antimicrobial Susceptibility Testing Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Veterinary Antimicrobial Susceptibility Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Company Usability Profiles: The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Veterinary Antimicrobial Susceptibility Testing Market, including Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bioguard Corporation, Biomérieux Sa., Bruker Corporation, Condalab, Cornell University (Animal Health Diagnostic Center), Danaher Corporation, Fastinov Sa, Hardy Diagnostics, Himedia Laboratories, Idexx Reference Laboratories, Iowa State University (Veterinary Diagnostic Laboratory), Liofilchem Srl., Mast Group Ltd., Neogen Corporation, Ssi Diagnostica A/S, Synbiosis, Thermo Fisher Scientific Inc., and University of Minnesota (Veterinary Diagnostic Laboratory).
The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as: 1. What is the market size and forecast of the Global Veterinary Antimicrobial Susceptibility Testing Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Veterinary Antimicrobial Susceptibility Testing Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Veterinary Antimicrobial Susceptibility Testing Market? 4. What is the competitive strategic window for opportunities in the Global Veterinary Antimicrobial Susceptibility Testing Market? 5. What are the technology trends and regulatory frameworks in the Global Veterinary Antimicrobial Susceptibility Testing Market? 6. What is the market share of the leading vendors in the Global Veterinary Antimicrobial Susceptibility Testing Market? 7. What modes and strategic moves are considered suitable for entering the Global Veterinary Antimicrobial Susceptibility Testing Market?
Our reports have been used by over 10K customers, including:
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 Market Impact) Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro...
The Global In Vitro Diagnostics Partnering Terms and Agreements 2014-2021 report provides a detailed understanding and analysis of how and why companies enter in vitro diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This...
Hematology Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Hematology Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics...
The in-vitro diagnostics market in Asia Pacific is expected to grow from US$ 13,729.8 million in 2019 to US$ 20,401.5 million by 2027; it is estimated to grow at a CAGR of 5.1% from 2020 to 2027. Incidence of chronic diseases such as cancers, chronic respiratory diseases, diabetes, and heart disease is growing due to biological risk factors,...
400 pages •
By The Business Research Company
• Feb 2021
Major companies in the in-vitro diagnostics market include Siemens Healthineers; F. Hoffmann-La Roche Ltd; Danaher (Beckman Coulter Inc); Abbott Laboratories Inc and Thermo Fisher Scientific Inc. The global in-vitro diagnostics market is expected to grow from $71.71 billion in 2020 to $80.12 billion in 2021 at a compound annual growth...
Report Scope Traditional medical devices include devices (e.g., metallic stents, heart valves, open procedures, general instruments, non-drug coated implantables, large endoscopes, needle-based drug delivery, lab-based diagnostics, etc.) that have been in use over the last 30 years for the treatment and management of various...
Global Cell Isolation Market By Product (Consumables and Instruments), By Cell Type (Human Cells and Animal Cells), By Source (Bone Marrow, Cord Blood/Embryonic Stem Cells, Adipose Tissue), By Technique (Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, Filtration-Based Cell Isolation), By Application (Biomolecule...
Report Scope: The scope of this study is global. The analyst examines each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging markets discussed include countries such as India, China, Korea, Taiwan, Africa, Australia, Brazil and Russia, among...
292 pages •
By Global Industry Analysts
• Apr 2021
- Global In Vitro Diagnostics Market to Reach $88.8 Billion by 2027
- Amid the COVID-19 crisis, the global market for In Vitro Diagnostics estimated at US$68.9 Billion in the year 2020, is projected to reach a revised size of US$88.8 Billion by 2027, growing at a CAGR of 3.7% over the analysis period 2020-2027....
In Vitro Diagnostics
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.